Concepedia

Javier Glez‐Vaz

JG

12

Publications

501

Citations

12

H-Index

2020

Active since

Affiliations

Navarre Institute of Health Research(Current)

Centro de Investigación Biomédica en Red de Cáncer

Clinica Universidad de Navarra

Universidad de Navarra

Instituto de Salud Carlos III

Javier Glez‐Vaz is an author at Navarre Institute of Health Research specializing in tumor immunity, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2020–2023

12

Publications

12

CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

Itziar Otano, Arantza Azpilikueta, Javier Glez‐Vaz et al. · Nature Communications · 2021 · 83 citations · Full text

Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils

Álvaro Teijeira, Saray Garasa, María C. Ochoa et al. · European Journal of Immunology · 2021 · 64 citations · Full text

CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary

Ignacio Melero, Miguel F. Sanmamed, Javier Glez‐Vaz et al. · Cancer Discovery · 2022 · 63 citations

A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β

Irene Olivera, Rebeca Sanz‐Pamplona, Elixabet Bolaños et al. · Cancer Discovery · 2022 · 52 citations · Full text

Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants

Enrique Conde, Enric Vercher, Marta Soria-Castellano et al. · Journal for ImmunoTherapy of Cancer · 2021 · 48 citations · Full text

Rows per page

1–5 of 12